Liquid Grids Announces Series A Funding and Appoints New Chairman

  Liquid Grids Announces Series A Funding and Appoints New Chairman

Business Wire

SAN DIEGO -- May 13, 2014

Liquid Grids^®, a Precision Marketing Platform marketing for the Healthcare
Industry, has recently completed a Series A investment round led by Miramar
Digital Ventures (MDV). The company has also appointed Daniel M. Bradbury,
former CEO of Amylin Pharmaceuticals, as new Chairman of the Board and added
Sherman Atkinson as a Director.

Through its proprietary analytics engine Liquid Grids has aggregated and
analyzed over 1 Billion healthcare conversations by over 125 million unique
healthcare consumers. The company identifies disease-specific personas, which
are scaled to deliver highly targeted, multi-channel advertising campaigns.
“Closing this round of investment is fueling a rapid scaling of the
opportunity we have cornered in the market and to extend our reach across the
industry,” says Malcolm Bohm, CEO of Liquid Grids.

“Traditional Direct to Consumer advertising is inefficient and delivers
irrelevant information to most people who receive it,” said Daniel M.
Bradbury, the newly appointed Chairman of the Board for Liquid Grids. “Liquid
Grids is the only company leveraging the power of the social networks to turn
DTC on its head and deliver real value to the healthcare industry’s marketing
spend.”

“Digital advertising within thehealth care space is growing exponentially,
andLiquid Grids is leading the industry with itspowerful analytics and
targeted buyer personas and inbound strategies," said Sherman Atkinson,
Managing Director of Miramar Digital Ventures. “We are very excited to have
added Liquid Grids to the Miramar Digital Ventures portfolio.”

About Liquid Grids®

Liquid Grids®, the pioneer in Direct to Persona Marketing®, is servicing
companies across the healthcare spectrum to deliver the most effective
contribution to digital and social media marketing and advertising campaigns.
By providing the most advanced and predictive intelligence available about
healthcare consumers, the platform drives insightful marketing strategies that
change the way the healthcare industry interacts with online health
communities. Learn more atwww.liquidgrids.com.

About Daniel M. Bradbury, Chairman of the Board

Daniel M. Bradbury has served as a director of Geron since September 2012. He
also serves as a member of the boards of directors of Illumina, Inc., a
manufacturer of life-science tools and integrated systems for the analysis of
genetic variation and biological function; Corcept Therapeutics, a company
focused on the discovery and development of drugs that regulate the effects of
cortisol; BioCon Ltd.,a company focused on reducing therapy costs of chronic
diseases like diabetes, cancer and autoimmune diseases; and BioMed Realty, a
real estate investment trust focused on providing real estate to the life
science industry, as well as being a member of the board of trustees of the
Keck Graduate Institute. He also serves on the University of California San
Diego, Rady School of Management's Advisory Council, the University of Miami's
Innovation Corporate Advisory Council, Investor Growth Capital Advisory Board
and the BioMed Ventures Advisory Committee. Mr. Bradbury served as Chief
Executive Officer of Amylin Pharmaceuticals, Inc., a biopharmaceutical company
focused on diabetes and metabolic disorders, from March 2007 until its
acquisition by Bristol-Myers Squibb Company in August 2012. Mr. Bradbury
served as Amylin's President from June 2006 until March 2007, as Chief
Operating Officer from June 2003 until June 2006, as Executive Vice President
from June 2000 until June 2003 and in other positions in corporate development
and marketing from 1994 until 2000. In addition, Mr. Bradbury served as a
member of the board of directors of Amylin from June 2006 until August 2012.
Prior to joining Amylin, he spent ten years at SmithKline Beecham
Pharmaceuticals, a pharmaceutical company, holding a number of sales and
marketing positions. He received a Bachelor of Pharmacy from Nottingham
University and a Diploma in Management Studies from Harrow and Ealing Colleges
of Higher Education in the United Kingdom.

About Miramar Digital Ventures

Miramar Digital Ventures (MDV) is a seed and early-stage fund uniquely focused
on investing in the most promising founders and market disruptive ideas. MDV,
located in Newport Beach, California and Park City, Utah, invests in companies
across North America as well as Hong Kong and mainland China.

Contact:

Liquid Grids
Chris Warden
Public Relations
858-609-9294
chris@liquidgrids.com
 
Press spacebar to pause and continue. Press esc to stop.